These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2483702

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of increased sulfation of dermatan sulfate on its in vitro and in vivo pharmacological properties.
    Dol F, Caranobe C, Dupouy D, Petitou M, Lormeau JC, Choay J, Sié P, Boneu B.
    Thromb Res; 1988 Oct 15; 52(2):153-64. PubMed ID: 3194890
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of dermatan sulfate in the rabbit after intravenous injection.
    Dol F, Houin G, Dupouy D, Cadroy Y, Caranobe C, Gabaig AM, Mardiguian J, Sié P, Boneu B.
    Thromb Haemost; 1988 Apr 08; 59(2):255-8. PubMed ID: 3388296
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antithrombotic and anticomplementary properties of a very low molecular mass dermatan sulfate.
    Fabiana Alberto M, Giaquinta Romero D, Lazzari M, Calabrese GC.
    Thromb Res; 2008 Apr 08; 122(1):109-16. PubMed ID: 17936880
    [Abstract] [Full Text] [Related]

  • 10. [Dermatan sulfate and the prevention of experimental venous thrombosis].
    Desnoyers P, Bara L, Samama M.
    Pathol Biol (Paris); 1989 Jun 08; 37(6):759-67. PubMed ID: 2674877
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A small fraction of dermatan sulfate with significantly increased anticoagulant activity was selected by interaction with the first complement protein.
    Calabrese GC, Alberto MF, Tubio R, Marani MM, Fernández De Recondo ME, Lazzari M, Recondo EF.
    Thromb Res; 2004 Jun 08; 113(3-4):243-50. PubMed ID: 15140589
    [Abstract] [Full Text] [Related]

  • 17. Effects of low-molecular-weight dermatan sulfate on coagulation, fibrinolysis and tissue factor pathway inhibitor in healthy volunteers.
    Harenberg J, Jeschek M, Acker M, Malsch R, Huhle G, Heene DL.
    Blood Coagul Fibrinolysis; 1996 Jan 08; 7(1):49-56. PubMed ID: 8845462
    [Abstract] [Full Text] [Related]

  • 18. Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate.
    Ofosu FA, Fernandez F, Gauthier D, Buchanan MR.
    Semin Thromb Hemost; 1985 Apr 08; 11(2):133-7. PubMed ID: 3898370
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacodynamics and pharmacokinetics of dermatan sulfate in humans.
    Dol F, Houin G, Rostin M, Montastruc JL, Dupouy D, Gianese F, Sie P, Boneu B.
    Blood; 1989 Oct 08; 74(5):1577-82. PubMed ID: 2790187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.